News about University Research Park tenants.
If you have a news article or announcement you'd like considered for our news room, please e-mail a copy of the article to firstname.lastname@example.org.
March 28, 2013
Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health.
The funds will speed the company’s work on a new, cost-effective system for producing stem cells and transforming them into specific cell lines, such as blood, liver and neural cells, said chief executive Chuck Oehler. Primorigen will collaborate on the project with EMD Millipore Corp., a division of Merck.
January 16, 2013
Stratatech Corp., a leader in regenerative medicine, today announced top-line results from its proof-of-concept clinical trial of StrataGraft®, a universal human skin substitute being developed for the treatment of severe burns.
September 29, 2012
Madison medical device company Stealth Therapeutics is marking a big milestone: Its Invisiport has been implanted in the first patient, an 18-year-old northern California woman.
June 15, 2012
Quintessence Biosciences will be meeting with potential development partners at the BIO Business Forum at the 2012 BIO International Convention (June 18-21 in Boston).
May 31, 2012
Quintessence today announced that the ongoing Phase 1 trial for their lead EVade™ Ribonuclease, called QBI-139, will be presented at the American Society of Clinical Oncology Annual Meeting.
May 28, 2012
Life Technologies, a Carlsbad, California-based company, with Madison offices at University Research Park, has a long tradition of sending employees to nonprofits to volunteer.
April 1, 2012
University Research Park companies that work with stem cells or make products used in the work include: Cellular Dynamics International, WiCell Research Institute, Stemina Biomarker Discovery, CellCura, Cell Line Genetics, InvivoSciences, and Primorigen Biosciences.